Santen Pharmaceutical , Ltd. Total Liabilities

Santen Pharmaceutical , Ltd. (SNPHF) currently reports a total liabilities of $120B as of June 2026. That compares with $130B in the prior-year period — down 9.5% year over year. Use the charts on this page to explore Santen Pharmaceutical , Ltd.'s total liabilities history and peer comparisons.

Santen Pharmaceutical , Ltd.'s total liabilities decreased from $130B to $120B — a 9.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Santen Pharmaceutical , Ltd. reported $120B in total liabilities as of June 2026. That compares with $130B in the prior-year period — down 9.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $120B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Santen Pharmaceutical , Ltd., and consider following SNPHF for alerts when major investors trade the stock.